Kineta Inc is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives... Show more
Get AI intraday signals
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.